Estimated Costs of 4-Month Pulmonary Tuberculosis Treatment Regimen, United States
Emerging Infectious Diseases · 2023
DOI: 10.3201/eid2910.230314 ↗Kurz gefasst
Fachartikel in der Zeitschrift Emerging Infectious Diseases, 2023. Verfasst von Carla A Winston und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Health Care Costs, Tuberculosis, Pulmonary. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
We estimated direct costs of a 4-month or 6-month regimen for drug-susceptible pulmonary tuberculosis treatment in the United States. Costs were $23,000 per person treated. Actual treatment costs will vary depending on examination and medication charges, as well as expenses associated with directly observed therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Zitieren
APA
Winston, C. A., Marks, S. M., & Carr, W. (2023). Estimated Costs of 4-Month Pulmonary Tuberculosis Treatment Regimen, United States. Emerging Infectious Diseases. https://doi.org/10.3201/eid2910.230314
Vancouver
Winston CA, Marks SM, Carr W. Estimated Costs of 4-Month Pulmonary Tuberculosis Treatment Regimen, United States. Emerging Infectious Diseases. 2023. doi:10.3201/eid2910.230314
BibTeX
@article{Winston2023,
author = {Winston, Carla A and Marks, Suzanne M and Carr, Wendy},
title = {Estimated Costs of 4-Month Pulmonary Tuberculosis Treatment Regimen, United States},
journal = {Emerging Infectious Diseases},
year = {2023},
doi = {10.3201/eid2910.230314}
}
EUVIMED